Biologics, also known as ‘biopharmaceuticals’, are therapeutic products created through the manipulation of biological sources.
![UTS Biologics Innovation Facility (BIF)](/sites/default/files/styles/full_width_small_1x/public/2019-07/gmp-bif-banner2_1.png?itok=3BcDNu3y)
What are Biologics?
Biologics explained
Biologics differ from traditional pharmaceuticals which are chemically synthesised. Bioprocessing is the process in which living cells or their components are used to produce biologics. Biologics include vaccines, gene therapies, cell therapies, engineered tissues and cells, target-specific antibodies, and hormones.
There is a growing global trend in biologics research and development which has led to innovative approaches to treating diseases, such as producing insulin from recombinant proteins in order to treat diabetes. The need to produce vaccines to target emerging diseases as well as the development monoclonal antibody treatments for cancer has contributed to the rapid growth of the biopharmaceutical industry.
The success of biologics can be seen through the profound impact of treatments in many medical fields, including rheumatology, cardiology, oncology, dermatology, and neurology. The future development of the biopharmaceutical industry can offer effective treatment and diagnosis for patients with previously untreatable diseases.
![A process engineer operating an Xcellerex XDR-200 single-use stirred-tank bioreactor.](/sites/default/files/styles/wysiwyg_generic_large_x1/public/2020-07/What%20are%20Biologics%20image%20A.jpg?itok=nX3kLhEm)
Enquiries
For more information about the training offered by BIF, please contact us
David Rickards, Biologics Innovation Facility Manager
Andrew Groth, Science faculty Business Development Manager
Email us